SLC2A1 and non-small cell lung carcinoma: Thus, the results suggest that GLUT1-mediated glucose metabolism may have two distinct but not mutually exclusive roles in NSCLC cells in that it not only contributes to gefitinib resistance but also to the growth of NSCLC cells as well.